Objectives: As an emerging risk factor for the rising incidence of type 2 diabetes, we examined sleep duration in relation to type 2 diabetes and several biomarkers. Design: Prospective cohort recruited [1993][1994][1995][1996]. Setting: The Multiethnic Cohort in Hawaii and California. Participants: A cohort of 151,691 White, African American, Japanese American, Native Hawaiian, and Latino participants; 9695 cohort members had biomarker measurements. Measurements: Sleep duration was self-reported at cohort entry. Diabetes status was obtained from 3 questionnaires and confirmed by 3 administrative data sources. Biomarkers were measured by standard assays 9.6 ± 2.1 years after cohort entry. We estimated diabetes risk as a time-varying outcome using Cox regression adjusted for body mass index assessed at 3 time points and other known confounders and computed adjusted means of biomarkers by sleep hours. Results: During 7.9 ± 3.5 years of follow-up, 8487 new diabetes cases were diagnosed. Long sleep duration (≥9 hours), as compared with 7-8 hours, was significantly associated with higher incidence (hazard ratio, 1.12; 95% confidence interval 1.04-1.21), but the 4% elevated incidence for short sleep duration (≤6 hours) did not reach significance (95% confidence interval 0.99-1.09). After stratification, the associations appeared stronger in Japanese American than other ethnic groups and in participants without comorbidity. Hours of sleep were positively associated with C-reactive protein and triglycerides and inversely related to high-density lipoprotein cholesterol and adiponectin but not with leptin levels and homeostatic model assessment of insulin resistance. Conclusion: In this multiethnic population, the 12% higher diabetes risk for long sleep hours may be mediated through inflammation, a poor lipid profile, and lower adiponectin levels.
The rising health burden due to type 2 diabetes around the world has stimulated a search for new etiologic factors. 1 Besides excess body weight, physical activity, and dietary composition, the role of the pineal hormone melatonin in transmitting circadian timing information to the pancreatic islets has emerged because it affects the blood glucose-regulating function of the islet cells and inhibits insulin secretion during the night. 2 In the last 50 years, the average selfreported sleep duration in the United States has decreased by 1.5-2 hours in parallel with an increasing prevalence of obesity and type 2 diabetes. 3 Strong epidemiologic evidence supports an association of sleep duration with diabetes development. In a pooled study 4 and in a later meta-analysis, 5 low (≤6) and high (≥8) hours of sleep predicted a higher risk in a U-shaped pattern with the lowest risk at 7-8 hours. The respective risk estimates per 1-hour shorter or longer sleep were 1.09 (95% confidence interval [CI], 1.04-1.15) and 1.14 (95% CI, 1.03-1.26). In the Multiethnic Cohort (MEC), short and long sleep duration was associated with 15%-25% higher all-cause and cardiovascular mortality. 6 In women only, diabetes-specific mortality was also elevated with short and long sleep duration. Despite this extensive evidence on the role of sleep in diabetes etiology, 7 a number Sleep Health 4 (2018) [27] [28] [29] [30] [31] [32] of questions remain open. First, less is known about this relation in non-White ethnic groups, although ethnic differences are likely given the high prevalence of obesity in some ethnic groups and stronger associations of obesity with type 2 diabetes incidence in Asians and Native Hawaiians than in Whites. [8] [9] [10] Second, confounding by obesity status is likely, and detailed information on body mass index (BMI) is needed. Third, biological mechanisms for a potential association are not well understood. C-reactive protein (CRP), highdensity lipoprotein cholesterol (HDL-C), triglycerides, leptin, and adiponectin are some of the possible mediators for sleep duration on diabetes risk. 11, 12 The current analysis determined the association of self-reported sleep duration assessed at cohort entry with diabetes incidence in 5 ethnic groups using self-reported diagnoses confirmed by administrative data and controlling for repeated BMI measures. In addition, possible biologic mechanisms for an association were examined using biomarkers of inflammation, adiposity, and metabolism among a subset of cohort members.
Participants and methods

Study population
The MEC was established in 1993-1996 to study the association of lifestyle and genetics with cancer and other chronic diseases among primarily Whites, Native Hawaiians, and Japanese Americans in Hawaii and African Americans and Latinos in California. 13 The study has been approved by the Institutional Review Boards of the University of Hawaii and the University of Southern California. A total of 215,831 participants aged 45-75 years at recruitment entered the cohort with a self-reported ethnic distribution of 26% Japanese American, 23% White, 22% Latino, 16% African American, 7% Native Hawaiian, and 6% Other. Depending on sex and ethnicity, the response rate varied between 19% and 51%. The MEC includes all education levels, although cohort members were somewhat better educated than the general population.
13
Questionnaire and follow-up data
At cohort entry in 1993-1996 (QX1), detailed exposure information was collected by means of a 26-page, self-administered questionnaire (Spanish version for Latinos in California in addition to English) 13 that included an extensive validated food frequency questionnaire specifically developed to include foods commonly consumed by the 5 ethnic groups, 14 height, body weight, physical activity, smoking, medications, medical conditions, family history, reproductive history, and demographics. Based on a large recipe database, 15 intakes of foods, nutrients, and total energy were computed. Physical activity was assessed by items asking about hours of sedentary, moderate, and vigorous activities; this information was used to compute daily metabolic equivalents of tasks (METs). The question "On the average, during the last year, how many hours in a day did you sleep including naps?" offered 6 categories (≤5, 6, 7, 8, 9 , and ≥10 hours). As partial validation, the association of habitual sleep duration with objective measures of energy balance was demonstrated in a small subset of White and African American cohort members. 16 When all 3 data sources were considered, 83% of self-reports were confirmed by at least 1 administrative data source. The major reasons for lack of confirmation were not being part of Medicare due to young age or managed care plans, not being a member of a linked health plan in Hawaii, and death.
Biomarker assays
In 2001-2006, a MEC biospecimen subcohort of 68,740 cohort members (49.7% of eligible) with morning blood samples from predominantly fasting individuals was established. Part of this cohort (n = 12,578) was characterized for a number of biomarkers by selecting controls from genetic case-control studies (breast, prostate, colorectal, and lung cancer). Only individuals who had fasted ≥8 hours and had not been diagnosed with diabetes before the blood draw were included in the analysis (N = 9700). Adiponectin and leptin from plasma were measured by enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Inc, Minneapolis, MN; cat. nos. DRP300 and DLP00). Insulin was assessed in serum using an ELISA kit (EMD Millipore, Billerica, MA; cat. no. EZHI-14K). All ELISA protocols were followed in accordance with the manufacturer's instruc- 
Statistical analysis
Of the total cohort, the following exclusions were made (some overlap), resulting in 151,691 observations: 13,994 other ethnicity, 28,153 prevalent diabetes at cohort entry, 9152 invalid diet, 7662 missing information on sleep variables, 3132 missing BMI, 22,045 missing physical activity, and 4 no follow-up time. Participants with missing smoking status were coded accordingly and included as a separate category. After applying a diabetes definition requiring a positive self-report and a claims diagnosis to maximize specificity, 8487 incident diabetes cases were identified.
Cox regression stratified by age (b55, 55-64, ≥65 years) was applied to assess the association between sleep hours and diabetes incidence by estimating hazard ratios (HRs) and 95% CI for 3 categories with 7-8 hours as the reference and for 6 categories with 7 hours as reference. Cases were censored at the earliest of time of first recorded diabetes diagnosis (year of QX or claim), whereas the follow-up time for noncases ended on the date when QX2 or QX3 was answered, at the end of the year before QX2 (1998) or QX3 (2002) was mailed for nonrespondents, or on the date of death. Based on previous analyses in the MEC, the following covariates were included 21, 22 : age at cohort entry, sex, ethnicity, education, BMI (time-varying from QX1 to 3), smoking status, physical activity (METs, log transformed), alcohol intake, total energy (log transformed), intake of red meat and dietary fiber (per 1000 kcal, log transformed), and coffee and soda consumption (servings/day). Effect modification by sex, ethnicity, age (b60 vs ≥60 years), BMI (b25 vs ≥25 kg/m 2 ), and presence of self-reported cardiovascular disease (heart attack or stroke) at cohort entry was evaluated by assessing the Wald statistic for cross-product interaction terms and by stratified analyses. For the biomarker analysis, general linear models were applied to compute geometric means for each of the 6 sleep duration categories while adjusting for the same covariates as in the Cox models. Trend tests were performed using continuous logtransformed biomarkers and HOMA-IR values to correct for the deviation of the distributions from normality and an ordinal variable [1] [2] [3] [4] [5] [6] to denote sleep duration.
Results
The current analysis was conducted among 69,097 men and 82,594 women with a nearly equal number of diabetes cases by sex (4204 men, 4283 women). The majority (57.8%) of cohort members reported 7-8 hours of sleep per day (Table 1) . For 6 categories of sleep duration, the respective proportions were 8.9% (≤5 hours), 24.6% (6 hours), 32.6% (7 hours), 25.2% (8 hours), 6.7% (9 hours), and 2.0% (≥10 hours). The age-adjusted incidence rates of diabetes across the 3 categories were 7.60 (≤6 hours), 6.68 (7-8 hours), and 8.48 (≥9 hours) per 1000 person-years. The distribution of sleeping hours did not differ much by sex; however, Japanese Americans were more likely to report short duration (≤6 hours) and Latinos and Whites more likely to report long duration (≥9 hours) than the other groups. Participants who reported more or less than 7-8 sleep hours were older and more likely to be obese and current smokers, and reported higher energy intake, less education, and less physical activity. BMI differed significantly (P b .0001) across sleep duration categories with respective values for the 3 categories of 26.5, 26.0, and 26.7 kg/m 2 . Overall, long but not short sleep duration was associated with incident type 2 diabetes among men and women (Table 2) ; the risk estimate among those sleeping ≥9 vs 7-8 hours was 1.12 (95% CI, 1.04-1.21), but short sleep duration (≤6 hours) did not reach significance (HR, 1.04; 95% CI, 0.99-1.09). In a model without BMI, the respective HRs for short and long sleep duration were 1.10 (95% CI, 1.05-1.15) and 1.14 (95% CI, 1.05-1.23), indicating that a small proportion of The interactions of sleeping duration with sex, age, and BMI were not significant, and the risk estimates were similar to the overall results without reaching statistical significance. Despite a nonstatistically significant interaction term (P interaction = .14), the risk estimates differed across ethnic groups. Only for Japanese Americans was diabetes incidence elevated for short (HR, 1.09; 95% CI, 1.01-1.18) and long duration (HR, 1.22; 95% CI, 1.05-1.43) of sleep. No statistically significant association of long sleep duration with diabetes incidence was seen for the other ethnic groups, although the relative risk estimates were greater than 1 for African Americans, Native Hawaiians, and Latinos. In Native Hawaiians only, short duration (≤6 hours) vs 7-8 hours of sleep was associated with a lower incidence (HR, 0.85; 95% CI, 0.74-0.98). In models stratified according to self-reported heart attack and stroke at cohort entry, only among participants without a comorbidity did long sleep duration predict a higher diabetes incidence (HR, 1.16; 95% CI, 1.07-1.25).
Of the current study population, 9700 (6.4%) participants without diabetes before blood draw had information for at least 1 biomarker assessed in fasting samples 9.7 ± 2.1 years after cohort entry. The percentages were similar for men (6.6%) and women (6.3%). By design, the ethnic distribution differed greatly: the proportion of Whites (1.4%) and Japanese Americans (5.1%) included was smaller, whereas relatively more African Americans (8.6%), Latinos (9.4%), and Native Hawaiians (17.9%) were part of the subcohort. The biomarker subcohort was relatively similar in age, BMI, education, and lifestyle factors to the analytic cohort but had fewer current smokers (11.9%) and participants with diabetes (n = 424). The 407 cases diagnosed before the blood draw were excluded from the biomarker analysis. The small number of incident diabetes cases after blood draw (n = 17) did not allow a formal mediation analysis. Because of missing measurements, the number of observations for individual biomarkers varied slightly (Table 3) .
Serum CRP was significantly higher by 0.32 mg/L (10%) with more sleep hours (Table 3) . Leptin levels showed little association with sleep duration, but adiponectin concentrations were 13% lower with more sleep (P trend = .0003). HDL-C (P trend b .0001) was lower and triglycerides were higher (P trend = .04) in the highest vs lowest sleep duration categories. The relation of fasting HOMA-IR with sleep hours was curvilinear with the highest value at 8 hours (P trend = .07). HRs and 95% CIs were obtained by Cox regression stratified by age at cohort entry (b55, 55-64, ≥65 years), adjusted for sex, BMI (time varying), ethnicity, smoking status, education, physical activity, alcohol intake, total energy intake, coffee intake, soda intake, red meat consumption, and dietary fiber intake. For comorbidity, 113 participants have missing information. a Geometric means adjusted for age at QX1; sex; ethnicity; BMI at QX1; smoking status; education; physical activity; and intake of total energy, alcohol, coffee, soda, red meat, and dietary fiber and excluding participants with b8 hours of fasting and a diagnosis of diabetes before blood collection. b P value obtained from general linear models using log-transformed values of biomarkers.
Discussion
Within this multiethnic population, longer sleep duration predicted a significant 12% higher risk of type 2 diabetes in men and women, whereas the 4% higher risk for short sleep duration (≤6 hours) as compared with those reporting 7-8 hours did not reach statistical significance. The association appeared stronger among MEC members without cardiovascular comorbidity, Japanese Americans reporting short and long sleep hours, and Native Hawaiians with short sleep duration. The biomarker findings support the idea that inflammation, a poor lipid profile, and low adiponectin levels, but not insulin resistance, mediate the association of long sleep hours with type 2 diabetes.
The current finding of shorter sleep duration among non-White ethnic groups agrees with national survey data 23 that reported shorter self-reported sleep hours for individuals with minority status and low socioeconomic status. The U-shaped pattern with the lowest risk at 7-8 hours and the higher diabetes incidence associated with long sleep hours is also consistent with previous reports. 4, 5 One meta-analysis 4 estimated a 50% higher incidence for long sleep duration (≥9 hours) and another one 5 a 14% higher incidence for each additional hour of sleep. However, the small risk estimate of 4% for short sleep duration (≤6 hours) in the MEC disagrees with previous estimates of a 28% higher risk for short sleep duration (≤6 hours) and 9% per hour. 4, 5 This may be due to the age structure of the MEC participants; a large proportion of the participants are retired and may not experience lack of sleep due to long working hours. Among the limited reports on ethnic differences, the Multi-Ethnic Study of Atherosclerosis described that short but not long sleep duration as assessed by an objective method was associated with a higher rate of abnormal fasting glucose, 24 but this relation disappeared after adjustment for sleep apnea and showed no evidence of interaction by ethnicity. In a cross-sectional analysis of the National Health and Nutrition Examination Survey, 25 7 hours of sleep was associated with the lowest cardiometabolic risk score in Whites, whereas African Americans had an optimal score at 8 hours of sleep. At this time, we cannot offer a definite explanation for the strong U-shaped association in Japanese Americans; underreporting of sleep, the possibility of good sleep quality and health status despite short hours, and residual confounding may be responsible. As to biologic mechanisms for an association between sleep and type 2 diabetes, insulin resistance, lower leptin levels, and systemic inflammation have been hypothesized. 12 Our findings agree with reports on higher CRP with longer sleep duration in a Cleveland report, 26 a survey of Taiwanese adults, 27 the Nurses' Health Study (NHS), 11 and an investigation among Japanese with long and short sleep duration. 28 Our findings related to HDL-C and triglycerides are similar to the Japanese study reporting a quadratic trend, 28 but the NHS showed no association for either biomarker. 11 Our null results on leptin agree with the NHS, 11 but the inverse association of adiponectin with sleep duration is contrary to the null findings in the NHS and the Taiwanese study. 11, 27 Sleep duration had a quadratic association with HOMA-IR in the Taiwanese study with the lowest level for 6.5-8.5 hours, 27 a result conflicting with the current study that detected the highest insulin resistance at 8 hours. This may be due to selection bias (only 6.4% of cohort members in the full analysis had biomarkers), incomplete case ascertainment, or an indication for mechanisms other than insulin resistance, although a U-shaped relation between sleep quantity and A1C levels in the United States National Health and Nutrition Examination Survey supported glucose control as a biologic mechanism. 29 In this large cohort with multiple data sources, self-reported diagnoses were highly consistent over 10 years of follow-up, and more than 80% of self-reported diagnoses were confirmed by administrative data sources. In general, self-reports of diabetes status were found to be fairly reliable in many previous studies [30] [31] [32] [33] despite some exceptions. 34 Because of changes in diabetes definition over time, a higher number of cases are to be expected among MEC participants during later observation years. 35 Other strengths of the study include a large sample size, the ethnic diversity, a wide range of diabetes incidence rates across ethnic groups, 36 the availability of important covariates associated with type 2 diabetes incidence, repeated assessments of BMI, and biomarker measurements for a substantial subset of the cohort. Limitations of the current study include potential errors in selfreports of sleep duration and the lack of information on sleep quality, apnea, and night shift work, which are predictors for type 2 diabetes in previous reports. For example, the risk was 5%-60% higher among rotating night shift workers in 2 US cohorts, 37 Japanese workers with poor sleep quality, 38 and Australian cohort members even after adjusting for baseline health. 39 The importance of sleep apnea was demonstrated in the Multi-Ethnic Study of Atherosclerosis report mentioned above. 24 As the biomarker subcohort did not equally represent all 5 ethnic groups in the MEC, the current results may have been affected by selection bias. Given the small number of incident diabetes cases with prediagnostic biomarkers, the mediating effect of biomarkers on the association between sleep hours and diabetes incidence could not be tested. The 1-time assessment of health status and biomarkers during the study period is another weakness, as levels may vary over time because of changes in lifestyle and health status. Furthermore, because of the collinearity between location (Hawaii vs Los Angeles) and ethnic group, it was not possible to separate the influence of these 2 variables on diabetes incidence.
Conclusions
The current analysis from the MEC detected a higher diabetes incidence among participants with long but not short sleep hours in the overall population after adjusting for BMI as a time-varying variable and a large number of known risk factors. As possible biologic mechanisms, higher inflammation, a worse lipid profile, and lower adiponectin levels detected in participants with the longest sleep hours may be responsible for the higher diabetes risk among long sleepers, but because of the selection of biomarker subcohort, the role of biomarkers as mediators could not be confirmed. The adverse influence of long sleep duration despite adjustment for changes in BMI over time and the inclusion of a large number of known nutritional, lifestyle, and anthropometric risk factors strengthens the evidence for this finding, although it cannot be ruled out that long sleep duration is the sign of underlying chronic disease, both diabetes and other conditions, a finding that may also be reflected in the biomarker levels. This study contributes novel findings related to ethnic differences to the growing literature related to the effects of sleep duration on physiological functions and disease risk, but the stronger association between sleep hours and diabetes incidence among Japanese Americans needs to be explored in future studies after including information on sleep quality.
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